chr5-135028798-G-C
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP3BS2
The NM_002653.5(PITX1):āc.926C>Gā(p.Ala309Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000344 in 1,454,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Synonymous variant affecting the same amino acid position (i.e. A309A) has been classified as Likely benign.
Frequency
Consequence
NM_002653.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PITX1 | NM_002653.5 | c.926C>G | p.Ala309Gly | missense_variant | 3/3 | ENST00000265340.12 | |
PITX1 | XM_047417318.1 | c.1028C>G | p.Ala343Gly | missense_variant | 4/4 | ||
PITX1 | XM_047417319.1 | c.581C>G | p.Ala194Gly | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PITX1 | ENST00000265340.12 | c.926C>G | p.Ala309Gly | missense_variant | 3/3 | 1 | NM_002653.5 | P1 | |
PITX1 | ENST00000506438.5 | c.926C>G | p.Ala309Gly | missense_variant | 4/4 | 1 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000213 AC: 5AN: 234434Hom.: 0 AF XY: 0.0000233 AC XY: 3AN XY: 128836
GnomAD4 exome AF: 0.00000344 AC: 5AN: 1454126Hom.: 0 Cov.: 32 AF XY: 0.00000415 AC XY: 3AN XY: 723128
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2023 | The c.926C>G (p.A309G) alteration is located in exon 3 (coding exon 3) of the PITX1 gene. This alteration results from a C to G substitution at nucleotide position 926, causing the alanine (A) at amino acid position 309 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at